Home Others Others Polyethylenimine

research use only

Polyethylenimine

Cat.No.E4019

Polyethylenimine (PEI) is a hydrophilic cationic polymer that acts as a low toxicity and efficient gene vector.
Polyethylenimine Chemical Structure

Chemical Structure

Molecular Weight: 43.07

Jump to

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 43.07 Formula

(C2H5N)x

 Storage (From the date of receipt) 2 years  -20°C  liquid
CAS No. 9002-98-6 -- Storage of Stock Solutions

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05644821 Recruiting
Prostate Cancer
Heinrich-Heine University Duesseldorf|Marienhospital Herne|University Hospital Essen|University Hospital Bonn|Klinikum Dortmund gGbmH|University Hospital Muenster|University Hospital of Cologne|University of Cologne|Techniker Krankenkasse|Deutsche Krebsgesellschaft e.V.
 August 1 2023 Not Applicable
NCT05804409 Not yet recruiting
Pancreatic Exocrine Insufficiency
Assiut University
 June 2023 --
NCT05266963 Enrolling by invitation
Type 1 Diabetes
Vanderbilt University Medical Center
 September 2 2022 Early Phase 1
NCT05244174 Recruiting
Pancreatic Neoplasm Malignant Head Primary|Pancreatic Exocrine Insufficiency
Hospital Clinico Universitario de Santiago
 January 25 2022 Not Applicable
NCT04548778 Recruiting
Exocrine Pancreatic Insufficiency
Bühlmann Laboratories AG
 November 1 2020 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.